4 Myelofibrosis Clinical Trials in Miami, FL (2026)

Q: How do I join a clinical trial in Miami?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you.

Recruiting Myelofibrosis Studies in Miami

NCT07357727Recruiting

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

The purpose of this trial is to evaluate whether treatment with pelabresib in combination with ruxolitinib leads to improved clinical outcomes compared to ruxolitinib alone in patients with primary my...

Miami, FLPHASE3460 participantsNovartis Pharmaceuticals

View Study Details

NCT07623161Recruiting

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

The main aim of this study is to find out how well elritercept works to improve anemia in participants with myelofibrosis (MF) who are taking ruxolitinib when compared to placebo. Other aims are to l...

Miami, FLPHASE3324 participantsTakeda

View Study Details

NCT04176198Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or...

Miami, FLPHASE1240 participantsSumitomo Pharma America, Inc.

View Study Details

NCT05320198Recruiting

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofi...

Miami, FLPHASE1150 participantsDisc Medicine, Inc

View Study Details

About Myelofibrosis Clinical Trials in Miami

Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.

There are currently 4 myelofibrosis clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 1,174 participants. Research is being sponsored by Novartis Pharmaceuticals, Takeda, Sumitomo Pharma America, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myelofibrosis Clinical Trials in Miami — FAQ

Are there myelofibrosis clinical trials in Miami?

Yes, there are 4 myelofibrosis clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What myelofibrosis treatments are being tested?

The 4 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.

Data updated October 14, 2026 from ClinicalTrials.gov